Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment

Atmaca, MUSTAFA; GÜLHAN, BORA; KORKMAZ, Emine; INOZU, Mihriban; Soylemezoglu, Oguz; CANDAN, CENGİZ; Bayazit, Aysun; Elmaci, Ahmet; Parmaksiz, Gonul; DÜZOVA, ALİ; Besbas, NESRİN; Topaloglu, REZAN; Ozaltin, FATİH

doi:10.1007/s00467-017-3634-3

Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment

Atıf İçin Kopyala

Atmaca M., GÜLHAN B., KORKMAZ E., INOZU M., Soylemezoglu O., CANDAN C., ...Daha Fazla

PEDIATRIC NEPHROLOGY, cilt.32, sa.8, ss.1369-1375, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 8
Basım Tarihi: 2017
Doi Numarası: 10.1007/s00467-017-3634-3
Dergi Adı: PEDIATRIC NEPHROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1369-1375
Anahtar Kelimeler: Adolescent, Nephrotic syndrome, Chronic kidney disease, ADCK4 mutation, CoQ10 supplementation, NEPHROTIC SYNDROME, STEROID-RESISTANT, REGISTRY, CHILDREN
Hacettepe Üniversitesi Adresli: Evet

Özet

ADCK4-related glomerulopathy is an important differential diagnosis in adolescents with steroid-resistant nephrotic syndrome (SRNS) and/or chronic kidney disease (CKD) of unknown origin. We screened adolescent patients to determine the frequency of ADCK4 mutation and the efficacy of early CoQ10 administration.